Institutional Ownership
Lyell Immunopharma Inc
CUSIP 55083R203COM NEWLYELQ1 2026
Institutional Holders
69
13F filers
Shares Held
11.14M
Aggregate institutional
Institutional Value
$220.25M
Q1 2026
Net New Holders
+5
14 new · 9 closed
Institutional Ownership Trend
Aggregate 13F value by quarter
Multi-quarter trend — upgrade to see history
UpgradePosition Activity
Q1 2026
New positions14
Increased24
Decreased8
Sold out9
Institutional Holders
69 funds hold this security · Q1 2026
| # | Fund | Shares | Value | Δ Shares | Activity |
|---|---|---|---|---|---|
| 1 | Arch Venture Management, LLC | 3.25M | $65.14M | +488.1K | Added |
| 2 | Gsk PLC | 1.51M | $30.34M | 0 | Held |
| 3 | Foresite Capital Management IV, LLC | 800.4K | $16.06M | 0 | Held |
| 4 | Orland Properties Ltd | 754.7K | $15.14M | 0 | Held |
| 5 | Almitas Capital LLC | 577.8K | $11.59M | 0 | Held |
| 6 | Foresite Capital Management V, LLC | 477.1K | $9.57M | 0 | Held |
| 7 | Millennium Management LLC | 458.9K | $9.21M | +400.3K | Added |
| 8 | Citadel Advisors LLC | 381.5K | $7.65M | +56.8K | Added |
| 9 | Venbio Partners LLC | 337.7K | $6.77M | 0 | Held |
| 10 | Susquehanna International Group, LLP | 310.2K | $6.22M | +159.2K | Added |
59 more institutional holders on Premium
See every fund holding Lyell Immunopharma Inc, with full quarter-over-quarter share changes.
Unlock all holders